Mr. Mani Jain appointed as CFO & KMP effective 27 April 2026

Management Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.5%Reaction day

₹37.50

prior close

₹37.50

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.2%-3.3% vs market

Pharmaceuticals peers, median of 165sector-0.3%-3.2% vs sector

On the reaction day the stock moved 3.3 pts less than Nifty Microcap 250 and 3.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.5-0.2-3.3-0.3-3.2

Next day

-4.4-0.2-4.2-0.4-4.0

-6.1-0.5-5.6-0.8-5.4

-6.7+0.9-7.6+0.6-7.3

-6.5+0.9-7.4+0.6-7.2

-3.2+2.5-5.7+1.9-5.1

+1.3+4.0-2.7+3.3-2.0

15d

-1.9-0.4-1.5+1.5-3.3

-2.7+2.4-5.1+3.0-5.7

-14.9+7.8-22.8+6.0-21.0

-16.2+8.0-24.2+6.4-22.6

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Kimia Biosciences Ltd has appointed Mr. Mani Jain as its Chief Financial Officer and Key Managerial Personnel, effective 27 April 2026. The announcement was filed with BSE. The available filing excerpt does not provide further details such as his prior experience, tenure, or the reason for the change in CFO role.

Likely market impact

A routine senior management appointment. New CFO may shape future financial strategy, capital allocation, and reporting. Monitor for continuity and execution.